Libtayo
List of products in the National Drug Code with proprietary name libtayo. Cemiplimab-rwlc is used to treat a certain type of skin cancer (cutaneous squamous cell carcinoma - CSCC). It works by changing the action of your own immune system, directing it to attack cancer cells. Cemiplimab-rwlc belongs to a class of drugs known as monoclonal antibodies.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 61755-008 | Libtayo | Cemiplimab-rwlc | Injection | Intravenous | Regeneron Pharmaceuticals, Inc. | Human Prescription Drug |